- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02162498
Study to Determine Impact of Feeding Buddies on Adherence to WHO PMTCT Guidelines in South Africa
Effect of Feeding Buddies on Adherence to WHO PMTCT Guidelines in South Africa
The 2010 revised WHO recommendations to provide antiretroviral (ARV) prophylaxis or treatment to mothers or infants during the breastfeeding period indicate a paradigm shift in prevention of mother-to-child transmission (PMTCT); care; and treatment programming. Yet despite South Africa's adoption of this guidance, myriad challenges currently exist. Confusion in the public health care system related to mixed messaging around safe infant feeding and the provision of-and now withdrawal of-free formula milk have made adherence to exclusive breastfeeding a challenge in South Africa. Cultural, social, and psychological factors influence the ability of women to follow PMTCT guidelines, which include exclusive breastfeeding for six months, adherence to ARV prophylaxis or treatment, and early infant diagnosis. Facility-based interventions alone are often inadequate to effect sustained behavioral changes in the face of multiple contextual factors. Community- and home-based support are needed, yet cost and systems constraints make these infeasible in many PMTCT programs. Some preliminary pilot data suggests that a feeding buddy strategy could fill this gap and provide a home-based support system for the mother. The feeding buddy, who is selected by an HIV-positive pregnant woman to support her in overcoming sociocultural challenges to adhering to various aspects of PMTCT programs, is not an employed health care worker, but rather an individual known to the mother, making the intervention extremely cost-effective, and requiring minimal resources to implement. In the Uthungulu District of KZN the Programme for Appropriate Technologies in Health (PATH) is implementing a programme (Window of Opportunity-WinOp) of improving health of mothers and infants, and the feeding buddy strategy is one of the strategies included in this overall package of care. While this strategy has been encouraged by the South African Department of Health, it has not previously been implemented nor obviously evaluated. In order to scale-up such a programme and justify the human resource costs, it is vital that such a programme be evaluated.
The goal of this proposed research study is therefore to evaluate the effect of the feeding buddy strategy to support mothers to adhere to PMTCT recommendations.
The investigators hypothesize that mothers who choose a feeding buddy will have increased rates of exclusive breastfeeding and adherence to ARV prophylaxis or treatment, as well as improved rates of early infant diagnosis and stigma reduction.
This evaluation will provide valuable information to the Department of Health in terms of choosing best practice models for promoting HIV-free infant survival and optimum health of infants in resource limited settings. The project plans to employ a cluster randomized intervention design and will include 300 mothers and their infants as well as the 300 buddies in the intervention group, as well as 300 mothers in the control group. All participants will be part of the WinOp feeding buddy intervention programme.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
KwaZulu-Natal
-
Durban, KwaZulu-Natal, South Africa
- University of KwaZulu-Natal
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria for pregnant women
- Pregnant women 18 years of age or older and attending one of the study clinics and enrolled in the national PMTCT program
- Women must be least 14 but not more than 28 weeks pregnant (defined using the date of the last menstrual period and clinical examination)
- They must have a documented HIV infection
- Have indicated their intention to deliver and remain within the study area for at least 6 months following the birth of their infant
- Committed to exclusively breastfeed
- Provide written informed consent
- Intervention mothers only: Must have agreed to participate in the WinOp feeding buddies program, and identified and disclosed to a feeding buddy
Exclusion criteria for pregnant women
- Women will be excluded from the study if they do not attend a study clinic
- If they are more than 28 weeks pregnant before enrollment
- If they indicate their intention to deliver or have postnatal visits outside the study area
- Intend to formula or mixed feed their infant
- Any participant that is seriously ill will be excluded from the study and referred for services and support
- Intervention mothers only: Not participating in the WinOp feeding buddies program
Inclusion criteria for buddies
- Participants will include people of any gender who are 18 years of age or older, who the mother has selected - HIV status will not be an inclusion criteria for this feeding buddy.
- Provide written informed consent
Exclusion criteria for buddies
- Potential participants will be excluded who are under the age of 18. HIV status is not an exclusion criteria for the feeding buddy.
- Any participant that is seriously ill will be excluded from the study and referred for services and support
Inclusion criteria for community care givers and PMTCT counselors (in-depth interviews only)
- Participants will include people of any gender who are 18 years of age or older, who serve as a community care giver or PMTCT counselor in the study sites.
- Provide written informed consent
Exclusion criteria for community care givers and PMTCT counselors (in-depth interviews only)
- Potential participants will be excluded who are under the age of 18 and who do not serve as a community care giver or PMTCT counselor in a study site.
- Any participant that is seriously ill will be excluded from the study and referred for services and support
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Feeding buddies intervention
Sites receiving a comprehensive feeding buddy program implemented by the Window of Opportunity program.
|
The Window of Opportunity program is implementing feeding buddies within their comprehensive programming. Their feeding buddies intervention targets all mothers at ANC for promoting health behaviors, especially exclusive breastfeeding. The NIH study is an implementation science award to evaluate the feeding buddies intervention, specifically among HIV positive recipients and evaluating the outcome of adherence to PMTCT recommendations. |
No Intervention: Standard of care
Sites from Window of Opportunity program who are not yet receiving the comprehensive feeding buddies program and are only receiving standard of care PMTCT support.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To determine the effect of a feeding buddy on adherence to exclusive breastfeeding.
Time Frame: 6 months postpartum
|
We hypothesize that mothers who choose a feeding buddy to provide enhanced support will have increased rates of initiation and duration of exclusive breastfeeding. Exclusive breastfeeding: Defined as no other food or drink, not even water, apart from breast milk (including expressed breast milk) with the exception of drops or syrups consisting of vitamins, mineral supplements or medicines (WHO/UNICEF. Infant and young child feeding counselling: an integrated course. Geneva: World Health Organization; 2006), measured by recall prior to each visit; from this aggregate data number of months engaged in EBF will be calculated. |
6 months postpartum
|
To determine the effect of a feeding buddy on adherence to ARV prophylaxis or ART regimens.
Time Frame: 6 months postpartum
|
We hypothesize that mothers who choose a feeding buddy to provide enhanced support will have increased rates of adherence to ARV prophylaxis or ART regimens. Adherence to ARV: Three separate outcomes will be examined, including adherence to:
Adherence to ARV in each case defined as taking more than 95% of prescribed doses.71 Adherence will be assessed through:
|
6 months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To determine the effect of a feeding buddy on adherence to infant HIV testing at 6 weeks.
Time Frame: 6 weeks postpartum
|
We hypothesize that mothers who choose a feeding buddy to provide enhanced support will have increased rates of having their infant tested for HIV at 6 weeks. Early infant HIV diagnosis: This will be examined through date of infant HIV PCR test as indicated through recall and medical record. |
6 weeks postpartum
|
To determine the effect of a feeding buddy on disclosure and stigma.
Time Frame: 6 months postpartum
|
We hypothesize that mothers who choose a feeding buddy will have increased rates of disclosure and decreased effect from stigma around HIV status. Impact on stigma and disclosure: This will be measured through descriptive analysis of perceived and enacted stigma associated with being HIV. Exposure: The exposure of interest is choosing a feeding buddy and level of exposure to the feeding buddy, the latter providing a dose-response measure of support. Exposure will be measured as having selected a buddy who has attended an orientation session (yes/no); number of visits to antenatal and postnatal visits accompanied by the feeding buddy; and the number, frequency, and type (in-person, telephone) of contacts between mother and buddy. |
6 months postpartum
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 5R01HD075090-02 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
-
University of Maryland, BaltimoreWithdrawnHiv | Kidney Transplant | HIV Reservoir | CCR5United States
Clinical Trials on Feeding buddies
-
University of ManitobaCompletedHealthy Children | Elementary School Age | Rural and Urban | First NationsCanada
-
Manulife Centre for Community Health ResearchWilfrid Laurier University; Kitchener Downtown Community Health Centre; Health...UnknownBreast Feeding
-
Guangdong Provincial Hospital of Traditional Chinese...RecruitingCritical Illness | Nutrition Disorders | Gastrointestinal DysfunctionChina
-
NestléCompleted
-
Tel-Aviv Sourasky Medical CenterCompleted
-
Taichung Veterans General HospitalUnknown
-
National University Hospital, SingaporeUnknownBronchopulmonary Dysplasia | Chronic Lung Disease of PrematurityMalaysia, Singapore
-
DHQ mardanDHQ HOSPITAL MARDANCompleted